First Patient Enrolled in U.S. LAA Stroke Study

First Patient Enrolled in U.S. LAA Stroke Study

Heart Arrhythmia specialist, J&J company, Biosense Webster, Inc. has enrolled the first patient in a study to evaluate the safety and effectiveness of a pioneering Left Atrial Appendage (LAA) closure treatment. The Biosense Webster, Inc. WaveCrest® Left Atrial Appendage Occlusion (LAAO)...

Latest News

Neural Analytics Raises $15M for Lucid Brain Monitor Development

Brain health specialist Neural Analytics, Inc., has raised $15 million to develop its Lucid System...

read the full article >

PMA Submitted for Pulmonx® Zephyr® Endobronchial Valve for Emphysema

Pulmonx® Corp. has filed a Premarket Approval (PMA) application with the U.S. FDA for the Zephyr®...

read the full article >

UK Specialist Healthcare Showcased at Arab Health

Arab Health is seemingly not just about technology, healthcare providers choosing to tell us how...

read the full article >

Cardiology

“Exceptional” Six-Week Stent Results Offer Hope to Severe Tricuspid Regurgitation Patients

Two "compassionate case" nonagenarian patients have benefitted from a catheter-guided tricuspid...

read the full article >

Abbott's MitraClip First Transcatheter Mitral Valve Repair Device Approved in Japan

Japan's Ministry of Health, Labour and Welfare(MHLW) has approved Abbott's MitraClip device for...

read the full article >

HighLife Closes €12.3 Million Financing Round

HighLife SAS, has announced the closing of a €12.3 million investment round led by Sofinnova...

read the full article >

Approvals / Clearance

FDA Clearance for MedShape DynaNail XL

Memory metal specialist MedShape, Inc., has received U.S. FDA 510(k) clearance for its DynaNail XL...

read the full article >

Radar Breast Tumor Localization Gets FDA Clearance for Long Term Implant

"Radar" implant, Cianna Medical's SAVI SCOUT® reflector can now be implanted for long term...

read the full article >

FDA Clears Stryker Cementless Mako Total Knee with Triathlon® Tritanium®

Stryker's Joint Replacement division has received U.S. FDA 510(k) market clearance for its...

read the full article >

Clinical Studies / Trials